Silencing herpes simplex virus with a vaginal microbicide.
Johnson
David C
DC
Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, USA.
D000282:Administration, Intravaginal; D000818:Animals; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D005260:Female; D020868:Gene Silencing; D015658:HIV Infections / Q000517:prevention & control; D006558:Herpes Genitalis / Q000517:prevention & control*; D018258:Herpesvirus 2, Human / Q000235:genetics*; D006801:Humans; D051379:Mice; D034741:RNA, Small Interfering / Q000378:metabolism / Q000627:therapeutic use*; D012367:RNA, Viral; D014621:Vagina / Q000821:virology
D000890:Anti-Infective Agents; D034741:RNA, Small Interfering; D012367:RNA, Viral